Molecular Partners Stock (NASDAQ: MOLN) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 168.000 / 14.202K |
Day Range | - - - |
52 Wk Range | 3.350 - 7.320 |
Market Cap | $132.074M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 51 |
Short Interest | - |
Days to Cover | 35.12 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Molecular Partners (NASDAQ: MOLN) through any online brokerage.
Other companies in Molecular Partners’s space includes: Syros Pharmaceuticals (NASDAQ:SYRS), Vincerx Pharma (NASDAQ:VINC), Galectin Therapeutics (NASDAQ:GALT), CytomX Therapeutics (NASDAQ:CTMX) and Vistagen Therapeutics (NASDAQ:VTGN).
The latest price target for Molecular Partners (NASDAQ: MOLN) was reported by JP Morgan on Tuesday, December 5, 2023. The analyst firm set a price target for 4.50 expecting MOLN to rise to within 12 months (a possible 11.94% upside). 1 analyst firms have reported ratings in the last year.
The stock price for Molecular Partners (NASDAQ: MOLN) is $4.02 last updated March 27, 2024 at 8:27 AM EDT.
There are no upcoming dividends for Molecular Partners.
Molecular Partners’s FY earnings are confirmed for Thursday, March 14, 2024.
There is no upcoming split for Molecular Partners.
Molecular Partners is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.